about
Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategyGliomas: diffusion kurtosis MR imaging in grading.Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?Re-irradiation or re-operation followed by dendritic cell vaccination? Comparison of two different salvage strategies for relapsed high-grade gliomas by means of a new prognostic model.Dendritic cell vaccination in patients with malignant gliomas: current status and future directions.Irradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma.DC vaccination with anti-CD25 treatment leads to long-term immunity against experimental glioma.Dendritic cell therapy of high-grade gliomas.Galectin-1 and immunotherapy for brain cancer.Primary brain tumours, meningiomas and brain metastases in pregnancy: report on 27 cases and review of literature.Immune Suppression during Oncolytic Virotherapy for High-Grade Glioma; Yes or No?Preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma.Characterization of PD-1 upregulation on tumor-infiltrating lymphocytes in human and murine gliomas and preclinical therapeutic blockade.Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administration.Dendritic cell vaccination for glioblastoma multiforme: review with focus on predictive factors for treatment response.Results of endoscopic third ventriculostomy in elderly patients ≥65 years of age.Galectin-1 in melanoma biology and related neo-angiogenesis processes.Persistent IL-10 production is required for glioma growth suppressive activity by Th1-directed effector cells after stimulation with tumor lysate-loaded dendritic cells.Family Caregivers of Patients With a High-Grade Glioma: A Qualitative Study of Their Lived Experience and Needs Related to Professional Care.Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death.Development and validation of a fully GMP-compliant production process of autologous, tumor-lysate-pulsed dendritic cells.Ependymomas of the filum terminale: The role of surgery and radiotherapy.Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study.Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumours.Transient local response and persistent tumor control in a child with recurrent malignant glioma: treatment with combination therapy including dendritic cell therapy. Case report.Uptake and presentation of malignant glioma tumor cell lysates by monocyte-derived dendritic cells.Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity.Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme.Living with a high-grade glioma: A qualitative study of patients' experiences and care needs.Should dendritic cell-based tumor vaccination be incorporated into standard therapy for newly diagnosed glioblastoma patients?A posttraumatic pontomedullary rent with good outcome.Altered galectin-1 serum levels in patients diagnosed with high-grade glioma.MR perfusion and diffusion imaging in the follow-up of recurrent glioblastoma treated with dendritic cell immunotherapy: a pilot study.Irradiation of necrotic tumor cells used to pulse dendritic cells (DCs) potentiates DC vaccine-induced anti-tumor immunity in a mouse model of high-grade gliomaOptimized preoperative motor cortex mapping in brain tumors using advanced processing of transcranial magnetic stimulation dataLong-lasting, complete exclusion of a large galenic dural arteriovenous fistula after clipping of the central venous aneurysm of the vein of galen: case reportAutomated speech analysis to improve TMS-based language mapping: Algorithm and proof of conceptGlioblastoma: To Target the Tumor Cell or the Microenvironment?Recurring Glioblastoma: A Case for Reoperation?
P50
Q33683101-C405E2AC-2076-4495-ADF1-01B0180A9058Q34189119-C62A3C91-C28B-451C-840B-DE3B32C1C92FQ34383339-E93E36BE-4A1F-4FD2-8DE2-DA0B326C7FBFQ35662578-9AE828D1-1D97-48FE-AB0B-04B7ECC1F3A7Q36672608-45B44AC8-C5DA-44E7-83DE-FC5BAF4C8AC9Q36710917-AEC58607-4A5F-4320-8761-313A24984F72Q37395354-1268F0B8-0D15-4C1E-9310-8A7F2F7D3DE2Q37594834-6FDBBB93-CF02-4DAB-82C2-38B66A119AE2Q37862237-95BF10A0-FD33-47CB-9637-B63ABB9D3648Q38196613-7A79C83F-D144-4816-9D12-4DF3493BD573Q38348844-19DBE1A3-1889-467B-8B63-906304114CE0Q38438763-17404BE8-F51D-4B22-858D-010A0384D1C2Q38691679-187D5F03-65AA-49B0-B0EB-E132547250EEQ38791872-CFFA3167-27DD-4F6A-98A6-9AE34651C624Q38912265-79399641-2230-4E57-9F05-21701CA751E8Q39195886-090AA0F8-62D6-4148-ACC9-5C533BC07FBCQ39343382-2E2A4119-DE6F-43D6-8910-675692B07CA6Q40158783-4B05CBF3-2E0F-405F-8173-427CDEE654D8Q41673089-892737F5-0403-4265-B279-E84B3B8BA608Q41744540-4C3956ED-3EBD-4169-B9BF-02B461721CC6Q42218510-17654909-4CB9-425C-81EA-DA3828EC737AQ42286406-EDA85C04-5225-4E18-9188-3E6D9C24B361Q43166491-93847F85-2BF1-4F0C-B029-06870272354EQ43256128-9C3B20CF-E0C5-4612-A94A-D27DA12D915DQ45002260-28894922-B437-405C-B8AB-D32911610420Q45251853-8C6BF271-1944-4F7F-87BD-086802A598F7Q45945651-E40BE471-4C8E-4719-9FD1-1261D0C9D192Q46593182-2873E673-309C-401D-8EED-A27EC30A34E8Q47572220-35D4C9A1-6AAC-4C8C-B48B-53830C5F5D5DQ48329275-5F6BC653-3859-4CEF-A29A-F47C958D19D2Q48954591-7213CC0E-608D-4174-8678-FFDD6CED85B1Q50860307-D654DA4D-5C86-4050-AAF4-132B65D6B4A6Q53258784-A24CF57D-501D-4DBC-8766-154D9AE7A737Q59320019-3A7A91BD-D2C2-4543-9227-D5515BA3DA19Q64261250-D5256BB4-3E30-466A-84B6-BF89EE6E62C8Q82768969-ECB12515-C0B6-4D94-8B13-0CF16151D47CQ90829191-ABBE41CA-3B4C-40CD-8606-BF519B3229F5Q95435287-87EA4ECD-E454-495F-8930-753AC85094B6Q95435334-5F8B5D31-AE2B-4932-87DF-2EAA55CEE9F1
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Steven De Vleeschouwer
@ast
Steven De Vleeschouwer
@en
Steven De Vleeschouwer
@es
Steven De Vleeschouwer
@nl
Steven De Vleeschouwer
@sl
type
label
Steven De Vleeschouwer
@ast
Steven De Vleeschouwer
@en
Steven De Vleeschouwer
@es
Steven De Vleeschouwer
@nl
Steven De Vleeschouwer
@sl
prefLabel
Steven De Vleeschouwer
@ast
Steven De Vleeschouwer
@en
Steven De Vleeschouwer
@es
Steven De Vleeschouwer
@nl
Steven De Vleeschouwer
@sl
P106
P21
P31
P496
0000-0002-9576-9917